FundedIQ
Biotechnology

Tourmaline Bio: Funding, Investors & Team (Sep 2026)

Tourmaline Bio is a biomedical firm that is dedicated to creating groundbreaking medications that can significantly enhance the well-being of patients and safeguard them against immune disorders.

www.tourmalinebio.com LinkedIn New York, United States 11-50 employees
Biotechnology Clinical Trials Therapeutics
Total raised
$75.0M
Rounds
1
Latest
Undisclosed round
Oct 2023

Tourmaline Bio has raised $75.0M across 1 funding round on record, the most recent an undisclosed round of $75.0M announced in Oct 2023.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Tourmaline Bio Company Profile and Key Stats

Total funding raised
$75.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$75.0M in Oct 2023
Employees
11-50
reported band
Headquarters
New York, United States

Latest funding round on record: Oct 2023.

Tourmaline Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$75.0M

Tourmaline Bio Founders and Leadership Team

Name
Role
Contact
Chris Beans
Founder
Locked

Contact details for the Tourmaline Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Tourmaline Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

Tourmaline Bio's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Tourmaline Bio in Biotechnology and New York

Companies Similar to Tourmaline Bio

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Tourmaline Bio Funding FAQs

What does Tourmaline Bio do?

Tourmaline Bio is a biomedical firm that is dedicated to creating groundbreaking medications that can significantly enhance the well-being of patients and safeguard them against immune disorders.

How much funding has Tourmaline Bio raised?

Tourmaline Bio has raised $75.0M across 1 round on record. The most recent is an undisclosed round of $75.0M announced in Oct 2023.

When did Tourmaline Bio last raise funding?

Tourmaline Bio's most recent funding round on record is an undisclosed round of $75.0M, announced in Oct 2023.

Who founded Tourmaline Bio?

FundedIQ lists Chris Beans (Founder) at Tourmaline Bio.

Where is Tourmaline Bio headquartered?

Tourmaline Bio is based in New York, United States.

How many employees does Tourmaline Bio have?

Tourmaline Bio is in the 11-50 employee band.

How does Tourmaline Bio's funding compare to other Biotechnology startups?

Tourmaline Bio's latest round of $75.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Tourmaline Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tourmaline Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.